Your browser doesn't support javascript.
loading
Rationale and design of a prospective, multicenter, phase II clinical trial of safety and efficacy evaluation of long course neoadjuvant chemoradiotherapy plus tislelizumab followed by total mesorectal excision for locally advanced rectal cancer (NCRT-PD1-LARC trial).
Yang, Zhengyang; Zhang, Xiao; Zhang, Jie; Gao, Jiale; Bai, Zhigang; Deng, Wei; Chen, Guangyong; An, Yongbo; Liu, Yishan; Wei, Qi; Han, Jiagang; Li, Ang; Liu, Gang; Sun, Yi; Kong, Dalu; Yao, Hongwei; Zhang, Zhongtao.
Afiliación
  • Yang Z; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University & National Clinical Research Center for Digestive Diseases, Beijing, China.
  • Zhang X; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University & National Clinical Research Center for Digestive Diseases, Beijing, China.
  • Zhang J; Department of Radiology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Gao J; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University & National Clinical Research Center for Digestive Diseases, Beijing, China.
  • Bai Z; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University & National Clinical Research Center for Digestive Diseases, Beijing, China.
  • Deng W; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University & National Clinical Research Center for Digestive Diseases, Beijing, China.
  • Chen G; Department of Pathology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • An Y; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University & National Clinical Research Center for Digestive Diseases, Beijing, China.
  • Liu Y; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University & National Clinical Research Center for Digestive Diseases, Beijing, China.
  • Wei Q; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University & National Clinical Research Center for Digestive Diseases, Beijing, China.
  • Han J; Department of General Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
  • Li A; Department of General Surgery, Beijing Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Liu G; Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, China.
  • Sun Y; Department of Anorectal, Tianjin People's Hospital, Tianjin, China.
  • Kong D; Department of Colorectal Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
  • Yao H; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University & National Clinical Research Center for Digestive Diseases, Beijing, China. zhangzht@ccmu.edu.cn.
  • Zhang Z; Department of General Surgery, Beijing Friendship Hospital, Capital Medical University & National Clinical Research Center for Digestive Diseases, Beijing, China. zhangzht@ccmu.edu.cn.
BMC Cancer ; 22(1): 462, 2022 Apr 27.
Article en En | MEDLINE | ID: mdl-35477432
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias del Recto / Neoplasias Primarias Secundarias / Terapia Neoadyuvante Tipo de estudio: Clinical_trials / Observational_studies Límite: Female / Humans / Male Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias del Recto / Neoplasias Primarias Secundarias / Terapia Neoadyuvante Tipo de estudio: Clinical_trials / Observational_studies Límite: Female / Humans / Male Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: China